Walgreens Boots Alliance Inc (WBA) Shares Sold by WASHINGTON TRUST Co

WASHINGTON TRUST Co lessened its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 30.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,827 shares of the pharmacy operator’s stock after selling 6,862 shares during the period. WASHINGTON TRUST Co’s holdings in Walgreens Boots Alliance were worth $1,222,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. American International Group Inc. raised its position in shares of Walgreens Boots Alliance by 1.9% during the 1st quarter. American International Group Inc. now owns 441,183 shares of the pharmacy operator’s stock valued at $36,640,000 after acquiring an additional 8,322 shares during the last quarter. Concert Wealth Management Inc. bought a new stake in shares of Walgreens Boots Alliance during the 1st quarter valued at $261,000. Cibc World Markets Corp raised its position in shares of Walgreens Boots Alliance by 8.8% during the 1st quarter. Cibc World Markets Corp now owns 374,075 shares of the pharmacy operator’s stock valued at $31,067,000 after acquiring an additional 30,341 shares during the last quarter. IFM Investors Pty Ltd raised its position in shares of Walgreens Boots Alliance by 0.8% during the 1st quarter. IFM Investors Pty Ltd now owns 11,790 shares of the pharmacy operator’s stock valued at $979,000 after acquiring an additional 92 shares during the last quarter. Finally, Cornerstone Capital Management Holdings LLC. raised its position in shares of Walgreens Boots Alliance by 30.0% during the 1st quarter. Cornerstone Capital Management Holdings LLC. now owns 288,216 shares of the pharmacy operator’s stock valued at $23,935,000 after acquiring an additional 66,580 shares during the last quarter. Hedge funds and other institutional investors own 61.41% of the company’s stock.

A number of research firms recently commented on WBA. Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Thursday, October 26th. Royal Bank of Canada began coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price objective for the company. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Robert W. Baird restated an “outperform” rating and issued a $80.00 price objective (down previously from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup lowered their price objective on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research report on Thursday, November 2nd. One analyst has rated the stock with a sell rating, nine have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $86.47.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $71.94 on Monday. The firm has a market cap of $71,246.21, a price-to-earnings ratio of 14.11, a P/E/G ratio of 1.28 and a beta of 1.22. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. Walgreens Boots Alliance Inc has a one year low of $63.82 and a one year high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.10. The firm had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.07 EPS. analysts predict that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.22%. The ex-dividend date of this dividend was Friday, November 10th. Walgreens Boots Alliance’s payout ratio is presently 42.33%.

Walgreens Boots Alliance declared that its Board of Directors has authorized a share buyback program on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to purchase shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, October 26th. The stock was bought at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by corporate insiders.

WARNING: This piece was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://sportsperspectives.com/2017/12/18/walgreens-boots-alliance-inc-wba-shares-sold-by-washington-trust-co.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply